Insider Notice: 4,796 MCB Shares to Be Sold (Form 144)
Rhea-AI Filing Summary
The filing is a Form 144 notification for the proposed sale of 4,796 shares of common stock to be executed on or about 08/19/2025 on the NYSE. The filing lists an aggregate market value of $347,228.36 and reports 10,421,384 shares outstanding. The 4,796 shares were acquired through restricted stock vesting on three dates—12/31/2021 (1,296 shares), 02/01/2023 (1,000 shares) and 01/24/2025 (2,500 shares)—and were issued as fees for service as director. The broker listed for the sale is Osaic Wealth, Inc., with an address in Red Bank, NJ. The filer certifies they are not aware of any undisclosed material adverse information about the issuer.
Positive
- Full disclosure of planned insider sale under Rule 144 for compliance purposes
- All shares originated from restricted stock vesting paid as fees for service as director, clearly documented
- Aggregate value provided: $347,228.36 and exchange specified as NYSE
Negative
- None.
Insights
TL;DR: Routine director stock sale; size is immaterial to outstanding shares and indicates compensation converted to liquid shares.
The filing documents a proposed sale of 4,796 shares representing approximately 0.046% of the 10,421,384 shares outstanding, with an aggregate value of $347,228.36. All shares were acquired via restricted stock vesting as director fees across three vesting events, so this appears to be a planned monetization of compensation rather than a sale prompted by company-specific news. The use of a broker (Osaic Wealth, Inc.) and the Form 144 notice indicates compliance with Rule 144 transfer requirements for an insider sale.
TL;DR: Standard insider disclosure consistent with director compensation vesting and planned sale under Rule 144.
The schedule shows the securities originated from restricted stock vesting tied to director fees on 12/31/2021, 02/01/2023, and 01/24/2025. The filer’s signature block includes the required representation about absence of undisclosed material adverse information. This filing satisfies disclosure obligations for an insider disposal and contains no governance red flags (e.g., accelerated or unusual stock grants) in the disclosed entries.